Condition
Low Grade Glioma of Brain clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Low Grade Glioma of Brain clinical trials that are recruiting, at sites in 3 countries (most in United States (4), France (1), Italy (1)). By phase: Phase 1 (1), Early Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 3Countries
Newest Low Grade Glioma of Brain clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Patient experiences during treatment for IDH‑mutant grade 2 gliomas: vorasidenib, radiotherapy, or observation | — | Milan | Recruiting | Apr 23, 2026 |
| Laser thermal therapy for young people with low-grade glioma | — | San Francisco, California | Recruiting | Apr 1, 2026 |
| Dabrafenib and trametinib dose-reduction for BRAF V600 low-grade glioma | Phase 2 | Birmingham, Alabama and 11 other locations | Recruiting | Aug 7, 2025 |
| Vorasidenib plus tumor-specific peptide vaccine for recurrent IDH1-mutant lower-grade glioma | Phase 1 | Durham, North Carolina | Recruiting | Nov 8, 2022 |
| Evaluating a new imaging method for low-grade brain tumors in children | Early Phase 1 | Philadelphia, Pennsylvania | Recruiting | Sep 27, 2022 |
| Mapping brain functions using electric stimulation during surgery | — | Montpellier | Recruiting | Jul 28, 2015 |
All recruiting trials (6)
-
Patient experiences during treatment for IDH‑mutant grade 2 gliomas: vorasidenib, radiotherapy, or observation
This project will test how adults with IDH‑mutant grade 2 gliomas feel—their quality of life, treatment symptoms, and anxiety—when they receive vorasidenib, radiotherapy, or active surveillance.
-
Laser thermal therapy for young people with low-grade glioma
This research will test whether laser interstitial thermal therapy (LITT) can stop or slow recurrent or progressive low-grade gliomas in children, adolescents, and young adults.
-
Dabrafenib and trametinib dose-reduction for BRAF V600 low-grade glioma
This trial tries to see if stopping or slowly lowering dabrafenib and trametinib after about 12–24 months works for people with BRAF V600–mutant low-grade glioma.
-
Vorasidenib plus tumor-specific peptide vaccine for recurrent IDH1-mutant lower-grade glioma
This will test whether combining the oral drug vorasidenib with a tumor-specific peptide vaccine helps adults with recurrent IDH1-mutant lower-grade glioma.
-
Evaluating a new imaging method for low-grade brain tumors in children
This study is testing a new imaging method to see if it can help doctors better monitor and manage low-grade brain tumors in children.
-
Mapping brain functions using electric stimulation during surgery
This study is testing how electric impulses during awake surgery for brain tumors can help us understand which parts of the brain are affected and how they work.
Related topics
Quick answers
How many Low Grade Glioma of Brain clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (4 trials), France (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Early Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.